Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7438902
Reference Type
Journal Article
Title
Hormones and Inflammation: An Update on Endometriosis
Author(s)
Pavone, D; Turrini, I; Sorbi, F; Vannuccini, S; Capezzuoli, T; Fambrini, M; Petraglia, F; ,
Year
2019
Page Numbers
177-192
DOI
10.1007/978-3-030-14358-9_14
URL
http://link.springer.com/10.1007/978-3-030-14358-9_14
Exit
Abstract
Endometriosis is a complex inflammatory, hormone-dependent disease that affects up to 10% of women in reproductive age, causing pain and infertility. Although the pathogenesis of this disease remains unknown, in the most recent decades, there has been a substantial progress toward unraveling the enigma associated with this disorder. The present chapter focuses on the influence of hormonal, immunological, and inflammatory pathways in the pathogenesis of endometriosis. The disease is characterized by an increased estrogen activity, which stimulates both eutopic and ectopic endometrial tissue proliferation; in addition, an aberrant response to progesterone, named progesterone resistance, has been shown. Stress hormones are involved in endometriosis pathogenesis. In the present chapter, the relevance of several key points in the inflammatory dysregulation contributing to endometriosis onset and progression, and related symptoms, will also be discussed. Immunological factors (cytokines, chemokines, and prostaglandins) as well as cell-mediated mechanisms play a major role in endometriosis-associated pain. Aberrant hormonal and inflammatory pathways contribute also to inflammatory comorbidities and adverse pregnancy outcome.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity